These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12016609)

  • 21. Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study.
    Marroquin B; Feng C; Balofsky A; Edwards K; Iqbal A; Kanel J; Jackson M; Newton M; Rothstein D; Wong E; Wissler R
    Int J Obstet Anesth; 2017 May; 30():16-22. PubMed ID: 28185794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences.
    Ripamonti C; De Conno F; Groff L; Belzile M; Pereira J; Hanson J; Bruera E
    Ann Oncol; 1998 Jan; 9(1):79-83. PubMed ID: 9541687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal therapy for chronic pain.
    Miles J
    Stereotact Funct Neurosurg; 2001; 77(1-4):156-8. PubMed ID: 12378067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The conversion challenge: from intrathecal to oral morphine.
    Sylvester RK; Lindsay SM; Schauer C
    Am J Hosp Palliat Care; 2004; 21(2):143-7. PubMed ID: 15055516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.
    Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L
    J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of intra-articular methadone on postoperative pain following anterior cruciate ligament reconstruction.
    Stewart DJ; Lambert EW; Stack KM; Pellegrini J; Unger DV; Hood RJ
    J Bone Joint Surg Am; 2005 Jan; 87(1):140-4. PubMed ID: 15634825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of methadone in cancer pain treatment--a review.
    Leppert W
    Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid therapy for chronic painful conditions.
    Burgess FW
    Med Health R I; 2001 Oct; 84(10):323-6. PubMed ID: 11693049
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.
    Santiago-Palma J; Khojainova N; Kornick C; Fischberg DJ; Primavera LH; Payne R; Manfredi P
    Cancer; 2001 Oct; 92(7):1919-25. PubMed ID: 11745266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study.
    Grochow L; Sheidler V; Grossman S; Green L; Enterline J
    Pain; 1989 Aug; 38(2):151-7. PubMed ID: 2488674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain.
    Gagnon B; Bruera E
    J Pain Symptom Manage; 1999 Aug; 18(2):120-5. PubMed ID: 10484859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report.
    Mercadante S; Sapio M; Serretta R; Caligara M
    Ann Oncol; 1996 Aug; 7(6):613-7. PubMed ID: 8879376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone titration in opioid-resistant cancer pain.
    Scholes CF; Gonty N; Trotman IF
    Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine infusor pump switch to oral methadone.
    Santos Suárez J; Del Valle Arnáez G
    BMJ Support Palliat Care; 2020 Mar; 10(1):1-3. PubMed ID: 30944123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine hyperalgesia: a case report.
    Wilson GR; Reisfield GM
    Am J Hosp Palliat Care; 2003; 20(6):459-61. PubMed ID: 14649563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.